[
  {
    "chunk_id": 0,
    "text": "CE: Swati; JH-D-20-00305; TotalnosofPages: 2; JH-D-20-00305 This Article Has Been Retracted Editorial Blood Hypertension medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project Reinhold Kreutza, Sverre E. Kjeldsenb, Michel Burnierc, Krzysztof Narkiewiczd, Suzanne Oparile, and Giuseppe Manciaf B ecause they were intrigued by the results, many described is an unclear process. The database appears colleagues and journalists have made ultrasound aware of asasummarydatabaseofmultiplesmallerstudiesalready the article Bedtime hypertension treatment completed and published, such as the MAPEC study 6, improvescardiovascularriskreduction: theHygiaChronowhichincluded2156hypertensivepatientsinanidentical therapyTrialbyHermidaetal. whichwaspublishedinthe protocol. There is no evidence that the strict rules that EuropeanHeartJournal1. Thepublicationandtheaccomapply to RCTs were implemented, no indication of how panyingeditorial2havereceivedagreatdealofattention theconductofthestudywasmonitoredandnodocumenin Europe, the United Kingdom and the USA (https: // tation of the membership of the event adjudication comwww. jwatch. org/na51128/2020/03/17/taking-antihypermittee or of audit by independent investigators. For tension-medications-night-interview). We continue to be example, it is unclear how the investigators assessed concerned by several aspects of the study. and dealt with potential adverse eventsoccurring during First, wefinditstrangethatalargerandomizedclinical the night. trial (RCT) with 19084 enrolled patients conducted We are very concerned about this approach, consein Europe over many years could have escaped our quently, we contacted some key opinion leaders in ultrasound attention with very little reporting on it at meetings or and in some European countries to gather their positions in preliminary publications. The 2019 publication cited on the paper. The responses received in November 2019 above, tooursurprise, reportedessentiallythesamedata were shocking. The email responses were included in a previouslyreportedin2018inthesamejournal3, again claim package that we submitted to the Editor-in-Chief of with an accompanying editorial 4. While in the current the European Heart Journal, who forwarded them for article the authors stated in the Abstract In this multifurtherscrutinytotheJournalsEthicalCommittee. Original centre, controlled, prospective endpoint trial, 19, 084 email texts and other materials are on file. hypertensive patients were assigned (1: 1), they stated When evaluating the patient characteristics and their in the former 2018 paper We prospectively evaluated changesovertheperiodoffollow-upmultipleissuesarose. 18, 078 individuals with baseline ambulatory blood pressure ranging Further detailed discussion questioning the plausibility of from normal Blood Hypertension to hypertension. However, thereporteddatafromaclinicalpointofviewisbeyondthe when reading the 2018 article, including its Table S1, it scope of this paper. became evident that the 2018 European Heart Journal According to the initial protocol (ClinicalTrials. gov article was a preliminary report of the current endpoint NCT00741585) the authors engaged 20 centers to perform trial. In the current article 1, we were surprised by the the study, but this grew to 40 centers and 292 physicians lack of supplementary material showing more details of doingyearly48-hambulatorybloodpressuremeasurement the protocol and data analysis, including assessment of endpointsusingaprospectiverandomizedopenblinded endpoint design. Our reading of the protocol article 5 JournalofHypertension2020, 38: 000000 suggested to ultrasound that no properly randomized RCT had aDepartmentofClinicalPharmacologyandToxicology, Charite UniversityMedicine, been performed. Berlin, Germany, bDepartmentofCardiology, UniversityofOslo, UllevaalHospital, Thestudyprotocolpublishedin2008onClinicalTrials. Oslo, Norway, cServiceofNephrologyandHypertension, CentreHospitalierUniversigov initially anticipated the recruitment of 5000 patients. taireVaudois, Lausanne, Switzerland, dDepartmentofHypertensionandDiabetology, MedicalUniversityofGdansk, Gdansk, Poland, eVascularBiologyandHypertension Actual recruitment began in 2007 and, without evident Program, DepartmentofMedicine, UniversityofAlabamaatBirmingham, Birmingjustification, intended enrolment increased to 15000 ham, Alabama, USAandfUniversityofMilano-Bicocca, Milan, Italy in 2014 and 18000 in 2016. This marked increase is Correspondence to Reinhold Kreutz, Department of Clinical Pharmacology and surprising, asinthepublishedprotocol5, 10700individToxicology, Charite UniversityMedicine, Berlin, Germany. E-mail: reinhold. kreutzcharite. de uals would have been sufficient for the detection of a Received23March2020Accepted30March2020 reduction in morbidity/mortality of more than 20% JHypertens38: 000000Copyright(cid: 2)2020WoltersKluwerHealth, Inc. Allrights afteramedianfollow-upof5years. Ofnote, theprimary reserved. endpoint included 15 items. The randomization DOI: 10. 1097/HJH. 0000000000002479 JournalofHypertension www. jhypertension. com 1 Copyright 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.",
    "word_count": 594,
    "char_count": 5256,
    "sentence_count": 39,
    "metadata": {
      "source_file": "blood_pressure_medication_should_not_be_routinely.96943.pdf",
      "extraction_date": "2025-12-31T14:50:10.320389",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "nephrology"
      ],
      "chunk_index": 0,
      "total_chunks": 3,
      "position": "1/3",
      "section": "CE:",
      "content_type": "evidence",
      "content_type_confidence": 5,
      "medical_entities": [],
      "entity_count": 0
    }
  },
  {
    "chunk_id": 1,
    "text": "1097/HJH. 0000000000002479 JournalofHypertension www. jhypertension. com 1 Copyright 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. CE: Swati; JH-D-20-00305; TotalnosofPages: 2; JH-D-20-00305 This Article Has Been Retracted Kreutz etal. (ABPM) on 19000 patients. On this background, only 607 ACKNOWLEDGEMENTS patientsdroppedoutbecauseofinappropriate48-hmeasurements thisseemsimpossibleifonetakesintoaccount TheeditorialisissuedjointlybyBloodPressureandJournal the known difficulties that one encounters when using of Hypertension, which are the two journals endorsed by ABPM devices. Moreover, from a methodological point theEuropeanSocietyofHypertension. R. potassium. ispresidentof of view, one of our colleagues carried out a technical the European Society of Hypertension. S. E. potassium. , M. B. , potassium. N. assessment of the HYGIA project. ABPM were made with and S. O. are editors of Blood Hypertension. G. M. is editor of Spacelabs instruments that barely last 48h in clinical use Journal of Hypertension. R. potassium. , S. E. potassium. , M. B. , potassium. N. , S. O. and even when rechargeable batteries were used. Performing G. M. report no relevant conflicts of interest to disclose 48h measurements on more than 19000 patients annually related to this editorial. wouldresultinanenormousbatteryconsumption. Atlast, in total, the HYGIA study should have produced Conflicts of interest over 150000 long-term blood pressure measurements with a failure There are no conflicts of interest. rateoflessthan10% whichwecannotachieveinclinical use not even with Spacelabs devices. Another point is REFERENCES data consolidation. The solution offered by Spacelabs 1. HermidaRC, CrespoJJ, Dominguez-SardinaM, OteroA, MoyaA, Rios appears not suitable for handling such a large potential MT, et al. Bedtime hypertension treatment improves cardiovascular set of data. riskreduction: theHygiaChronotherapyTrial. EurHeartJ2019; 20: 97; The impact of a paper published in European Heart doi: 10. 1093/eurheartj/ehz754. Journal is large. Journalists in Good faith will continue 2. MathurP, KadavathS, MarshJD, MehtaJL. Chronotherapyforhypertension: improvementinpatientoutcomeswithbedtimeadministrawriting about the study in newspapers and other venues, tion of antihypertensive drugs. Eur Heart J 2019; pii: ehz836; doi: and patients may start following this untoward advice, 10. 1093/eurheartj/ehz836. namely taking some of their blood pressure-lowering medication at 3. HermidaRC, CrespoJJ, OteroA, Dominguez-SardinaM, MoyaA, Rios bedtime. Ouropinionisthatthisisundocumentedandcan MT, et al. Asleep Blood Hypertension: significant prognostic marker of be dangerous for many patients who experience very Low vascularriskandtherapeutictargetforprevention. EurHeartJ2018; 39: 41594171. BPinthemiddleofthenight. Excessivenighttimelowering 4. BrunoRM, TaddeiS. Asleepbloodpressure: atargetforcardiovascular of blood pressure, including over-dipping or extreme-dipping, has eventreduction? EurHeartJ2018; 39: 41724174. been associated with an increased risk of ischemia in 5. Hermida RC. Sleep-time ambulatory Blood Hypertension as a prognostic patients with coronary Heart disease 7 and an increased markerofvascularandotherrisksandtherapeutictargetforprevention by hypertension chronotherapy: rationale and design of the Hygia riskofdevelopingsilentcerebralinfarcts8. Theserisksare Project. ChronobiolInt2016; 33: 906936. especially great in older patients 9, 10. 6. HermidaRC, AyalaDE, MojonA, FernandezJR. Influenceofcircadian Further, it has been shown using the Medication Event timeofhypertensiontreatmentoncardiovascularrisk: resultsofthe Monitoring System that drug adherence is significantly MAPECstudy. ChronobiolInt2010; 27: 16291651. lowerwhendrugsaretakenintheeveningwhencompared 7. Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, MezzettiA. Circadianbloodpressurechangesandmyocardialischemia with taking medication in the morning 11. inhypertensivepatientswithcoronaryarterydisease. JAmCollCardiol We consider the situation very serious. As editors of 1998; 31: 16271634. journalsendorsedbytheEuropeanSocietyofHypertension 8. KarioK, PickeringTG, MatsuoT, HoshideS, SchwartzJE, ShimadaK. and/or present or past members of the European or ultrasound Strokeprognosisandabnormalnocturnalbloodpressurefallsinolder hypertensives. Hypertension2001; 38: 852857. Hypertension Guidelines Committee, we feel responsible 9. SuzukiY, KuwajimaI, AonoT, KanemaruA, NishinagaM, ShibataH, etal. to send out this message: Prognosticvalueofnighttimebloodpressureintheelderly: aprospective The reported data from the HYGIA project must be studyof24-hbloodpressure. HypertensRes2000; 23: 323330. interpreted with great caution. In our opinion, THERE 10. PierdomenicoSD, PierdomenicoAM, CoccinaF, LapennaD, PorrecaE. IS NO RELIABLE EVIDENCE THAT Blood Hypertension Circadianbloodpressurechangesandcardiovascularriskinelderlytreatedhypertensivepatients. HypertensRes2016; 39: 805811. LOWERING MEDICATIONS SHOULD BE ROUTINELY 11. VrijensB, VinczeG, KristantoP, UrquhartJ, BurnierM. Adherenceto DOSED AT BEDTIME, UNLESS THERE IS A SPECIFIC prescribed antihypertensive drug treatments: longitudinal study of EVIDENCE-SUPPORTED INDICATION. electronicallycompileddosinghistories.",
    "word_count": 599,
    "char_count": 5324,
    "sentence_count": 74,
    "metadata": {
      "source_file": "blood_pressure_medication_should_not_be_routinely.96943.pdf",
      "extraction_date": "2025-12-31T14:50:10.320389",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "nephrology"
      ],
      "chunk_index": 1,
      "total_chunks": 3,
      "position": "2/3",
      "content_type": "treatment",
      "content_type_confidence": 6,
      "medical_entities": [
        "potassium",
        "antihypertensive",
        "adherence",
        "monitoring"
      ],
      "entity_count": 4
    }
  },
  {
    "chunk_id": 2,
    "text": "Adherenceto DOSED AT BEDTIME, UNLESS THERE IS A SPECIFIC prescribed antihypertensive drug treatments: longitudinal study of EVIDENCE-SUPPORTED INDICATION. electronicallycompileddosinghistories. BMJ2008; 336: 11141117. 2 www. jhypertension. com Volume38(cid: 2)Number1(cid: 2)Month2020 Copyright 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.",
    "word_count": 42,
    "char_count": 384,
    "sentence_count": 7,
    "metadata": {
      "source_file": "blood_pressure_medication_should_not_be_routinely.96943.pdf",
      "extraction_date": "2025-12-31T14:50:10.320389",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "nephrology"
      ],
      "chunk_index": 2,
      "total_chunks": 3,
      "position": "3/3",
      "content_type": "treatment",
      "content_type_confidence": 4,
      "medical_entities": [
        "antihypertensive"
      ],
      "entity_count": 1
    }
  }
]